FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34309111000001101: Magnesium hydroxide 7.45-8.35% oral suspension BP (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103844101000001115 Magnesium hydroxide 7.45-8.35% oral suspension BP (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103844201000001110 Magnesium hydroxide 7.45-8.35% oral suspension BP en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium hydroxide 7.45-8.35% oral suspension BP Is a Magnesium hydroxide true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspension.oral ontology form and route true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Is a Product containing magnesium hydroxide false Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Has active ingredient Magnesium hydroxide false Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Has specific active ingredient Magnesium hydroxide true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Phillips' Milk of Magnesia 415mg/5ml oral suspension (Omega Pharma Ltd) Is a True Magnesium hydroxide 7.45-8.35% oral suspension BP Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP (A A H Pharmaceuticals Ltd) Is a True Magnesium hydroxide 7.45-8.35% oral suspension BP Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP (Thornton & Ross Ltd) Is a True Magnesium hydroxide 7.45-8.35% oral suspension BP Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP 500 ml Has VMP True Magnesium hydroxide 7.45-8.35% oral suspension BP Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml Has VMP True Magnesium hydroxide 7.45-8.35% oral suspension BP Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start